BritLofex lofexidine: Britannia said a double-blind, placebo-controlled U.S. Phase III trial scheduled to enroll 96 patients was stopped early after an interim

Britannia Pharmaceuticals Ltd., London, U.K.
Product: BritLofex lofexidine
Business: Neurological

Read the full 102 word article

How to gain access

Continue reading with a
two-week free trial.